# Long Term Follow-up of Autologous Bone Marrow Mononuclear Cells Therapy in STEMI

> **NCT00626145** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Xijing Hospital** · enrollment: 37 (actual)

## Conditions studied

- Myocardial Infarction

## Interventions

- **PROCEDURE:** saline infusion
- **PROCEDURE:** autologous bone marrow mononuclear cells infusion

## Key facts

- **NCT ID:** NCT00626145
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-03
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2008-02-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00626145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00626145, "Long Term Follow-up of Autologous Bone Marrow Mononuclear Cells Therapy in STEMI". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00626145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*